Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Bortezomib × Clear all

Sponsor

Conditions

Multiple Myeloma 131 Lymphoma, Mantle-Cell 27 Neoplasms, Plasma Cell 19 Lymphoma, Follicular 19 Lymphoma 19 Lymphoma, Non-Hodgkin 18 Recurrence 15 Leukemia, Myeloid, Acute 12 Waldenstrom Macroglobulinemia 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 10 Immunoglobulin Light-chain Amyloidosis 10 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Neoplasms 7 Leukemia 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, B-Cell 4 Hematologic Diseases 4 Congenital Abnormalities 4 Brain Neoplasms 4 Amyloidosis 4 Paraproteinemias 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Erythroblastic, Acute 3 Leukemia, B-Cell 3

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡